Boston Scientific Corporation is a global developer, manufacturer, and marketer of medical devices used in a broad range of interventional medical specialties. The company is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Its products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions.
Serves as the global corporate headquarters, housing executive leadership, global administration, research and development, and strategic operations.
Modern campus with state-of-the-art R&D labs, employee amenities including fitness centers, collaborative workspaces, and focus on sustainable design.
Emphasizes innovation, collaboration, patient-centricity, and a commitment to diversity and inclusion. Fosters a high-performance environment driven by scientific advancement and improving patient outcomes.
Centralizes strategic decision-making and innovation efforts, driving the company's global mission to advance science for life.
Boston Scientific operates globally with a significant presence in the Americas, Europe, Middle East, Africa, and Asia-Pacific. Its functions supported globally include research and development, manufacturing, clinical trials, sales and marketing, distribution, and customer support for its diverse portfolio of medical devices across various therapeutic areas. The company has manufacturing facilities and R&D centers in multiple countries to cater to local and global needs.
300 Boston Scientific Way
Marlborough
MA
USA
Address: 4100 Hamline Ave N, Arden Hills, MN 55112, USA
Serves as a key center for innovation and product development for the North American market and global supply chain.
Address: Ballybrit Business Park, Galway, Ireland
Supports European operations, manufacturing for global distribution, and R&D for specific product lines.
Address: Nakano Central Park South, 4-10-2 Nakano, Nakano-ku, Tokyo 164-0001, Japan
Manages commercial activities and market access for Boston Scientific's products in Japan, a key Asia-Pacific market.
Address: 10 Raeburn Park, Block C, #02-08, Singapore 088702
Drives growth and market expansion in emerging and established markets across AMEA.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, boston' leadership includes:
boston has been backed by several prominent investors over the years, including:
Boston Scientific occasionally announces executive team updates reflecting strategic growth and leadership succession. In the past year, such changes have included appointments to key divisional leadership roles. The following are illustrative examples based on public announcements for named SVP+ roles; comprehensive tracking of all executive movements is extensive.
Discover the tools boston uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Boston Scientific commonly uses a standard email format for its employees, primarily based on the employee's first and last name. The domain used is @bsci.com.
firstname.lastname@bsci.com
Format
jane.doe@bsci.com
Example
85%
Success rate
Boston Scientific Newsroom • June 18, 2024
Boston Scientific has entered into a definitive agreement to acquire Silk Road Medical, a company focused on stroke prevention through innovative transcarotid artery revascularization (TCAR) products. The acquisition is valued at approximately $1.16 billion....more
Boston Scientific Newsroom • June 10, 2024
The U.S. Food and Drug Administration (FDA) has approved the WATCHMAN FLX™ Pro Left Atrial Appendage Closure (LAAC) Device. This next-generation device includes features designed to enhance visualization and procedural efficiency for physicians treating patients with non-valvular atrial fibrillation who are at increased risk of stroke....more
Boston Scientific Investor Relations • April 24, 2024
Boston Scientific reported strong financial results for the first quarter of 2024, with net sales of $3.856 billion, representing a 13.8% organic growth compared to the prior year period. The company also raised its full-year 2024 sales and earnings per share guidance....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including boston, are just a search away.